- Home
- MDXH vs OSTX Comparison
MDXH vs OSTX Comparison
Compare MDXH & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- OSTX
- Stock Information
- Founded
- MDXH 2003
- OSTX 2018
- Country
- MDXH Belgium
- OSTX United States
- Employees
- MDXH N/A
- OSTX N/A
- Industry
- MDXH
- OSTX
- Sector
- MDXH
- OSTX
- Exchange
- MDXH Nasdaq
- OSTX NYSE
- Market Cap
- MDXH 93.1M
- OSTX 109.6M
- IPO Year
- MDXH 2021
- OSTX 2024
- Fundamental
- Price
- MDXH $2.00
- OSTX $4.16
- Analyst Decision
- MDXH Strong Buy
- OSTX Strong Buy
- Analyst Count
- MDXH 2
- OSTX 2
- Target Price
- MDXH $7.00
- OSTX $14.50
- AVG Volume (30 Days)
- MDXH 136.8K
- OSTX 120.1K
- Earning Date
- MDXH 02-26-2025
- OSTX 02-15-2025
- Dividend Yield
- MDXH N/A
- OSTX N/A
- EPS Growth
- MDXH N/A
- OSTX N/A
- EPS
- MDXH N/A
- OSTX N/A
- Revenue
- MDXH $84,708,000.00
- OSTX N/A
- Revenue This Year
- MDXH $27.57
- OSTX N/A
- Revenue Next Year
- MDXH $20.09
- OSTX $26,663.99
- P/E Ratio
- MDXH N/A
- OSTX N/A
- Revenue Growth
- MDXH 33.01
- OSTX N/A
- 52 Week Low
- MDXH $1.55
- OSTX $1.58
- 52 Week High
- MDXH $4.44
- OSTX $6.48
- Technical
- Relative Strength Index (RSI)
- MDXH 40.19
- OSTX N/A
- Support Level
- MDXH $1.96
- OSTX N/A
- Resistance Level
- MDXH $2.25
- OSTX N/A
- Average True Range (ATR)
- MDXH 0.18
- OSTX 0.00
- MACD
- MDXH -0.05
- OSTX 0.00
- Stochastic Oscillator
- MDXH 5.71
- OSTX 0.00
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.